JP2004520292A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004520292A5 JP2004520292A5 JP2002547905A JP2002547905A JP2004520292A5 JP 2004520292 A5 JP2004520292 A5 JP 2004520292A5 JP 2002547905 A JP2002547905 A JP 2002547905A JP 2002547905 A JP2002547905 A JP 2002547905A JP 2004520292 A5 JP2004520292 A5 JP 2004520292A5
- Authority
- JP
- Japan
- Prior art keywords
- imidazole
- alkyl
- phenylethynyl
- methyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 44
- 229910052739 hydrogen Inorganic materials 0.000 claims 44
- 239000001257 hydrogen Substances 0.000 claims 44
- 150000002431 hydrogen Chemical class 0.000 claims 29
- 229910052736 halogen Inorganic materials 0.000 claims 27
- 239000003814 drug Substances 0.000 claims 22
- 150000002367 halogens Chemical class 0.000 claims 19
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 15
- 125000001072 heteroaryl group Chemical group 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- 125000003118 aryl group Chemical group 0.000 claims 9
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 229940079593 drug Drugs 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 102000012777 Metabotropic Glutamate 5 Receptor Human genes 0.000 claims 3
- 108010065028 Metabotropic Glutamate 5 Receptor Proteins 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 230000001404 mediated effect Effects 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- PUKYADSZRIFWBW-UHFFFAOYSA-N 1,2-dimethyl-5-nitro-4-(2-phenylethynyl)imidazole Chemical compound CN1C(C)=NC(C#CC=2C=CC=CC=2)=C1[N+]([O-])=O PUKYADSZRIFWBW-UHFFFAOYSA-N 0.000 claims 2
- LOTINBXYYHAHAS-UHFFFAOYSA-N 1-(2-phenylethynyl)imidazole Chemical compound C1=NC=CN1C#CC1=CC=CC=C1 LOTINBXYYHAHAS-UHFFFAOYSA-N 0.000 claims 2
- HHBOBGCMQRHARO-UHFFFAOYSA-N 1-[2-(2-methylphenyl)ethenyl]imidazole Chemical compound Cc1ccccc1C=Cn1ccnc1 HHBOBGCMQRHARO-UHFFFAOYSA-N 0.000 claims 2
- HSRTUFQSWUUUPW-UHFFFAOYSA-N 1-chloro-3-[2-methyl-5-nitro-4-(2-phenylethynyl)imidazol-1-yl]propan-2-ol Chemical compound ClCC(O)CN1C(C)=NC(C#CC=2C=CC=CC=2)=C1[N+]([O-])=O HSRTUFQSWUUUPW-UHFFFAOYSA-N 0.000 claims 2
- BYDVZOJERIILKV-UHFFFAOYSA-N 1-methyl-2-(2-phenylethenyl)-4,5-di(propan-2-yl)imidazole Chemical compound CN1C(C(C)C)=C(C(C)C)N=C1C=CC1=CC=CC=C1 BYDVZOJERIILKV-UHFFFAOYSA-N 0.000 claims 2
- RFYGKWHXFNNZNS-UHFFFAOYSA-N 1-methyl-4,5-di(propan-2-yl)-2-[2-(2,3,4-trimethoxyphenyl)ethenyl]imidazole Chemical compound COC1=C(OC)C(OC)=CC=C1C=CC1=NC(C(C)C)=C(C(C)C)N1C RFYGKWHXFNNZNS-UHFFFAOYSA-N 0.000 claims 2
- SNGCCBVREOHWKF-UHFFFAOYSA-N 1-methyl-4-(2-phenylethynyl)imidazole Chemical compound CN1C=NC(C#CC=2C=CC=CC=2)=C1 SNGCCBVREOHWKF-UHFFFAOYSA-N 0.000 claims 2
- NMVDYHCVYLHJGV-UHFFFAOYSA-N 1-methyl-5-(2-phenylethynyl)imidazole Chemical compound CN1C=NC=C1C#CC1=CC=CC=C1 NMVDYHCVYLHJGV-UHFFFAOYSA-N 0.000 claims 2
- IINJCOPQGPOWFH-UHFFFAOYSA-N 2-[2-(2,4-dichlorophenyl)ethenyl]-1-methyl-4,5-di(propan-2-yl)imidazole Chemical compound CN1C(C(C)C)=C(C(C)C)N=C1C=CC1=CC=C(Cl)C=C1Cl IINJCOPQGPOWFH-UHFFFAOYSA-N 0.000 claims 2
- JGOZTWVZFPRMKZ-UHFFFAOYSA-N 2-[2-(2-chlorophenyl)ethynyl]-1-methylimidazole Chemical compound CN1C=CN=C1C#CC1=CC=CC=C1Cl JGOZTWVZFPRMKZ-UHFFFAOYSA-N 0.000 claims 2
- GJTBRYJBWTXWBR-UHFFFAOYSA-N 2-[2-(2-fluorophenyl)ethynyl]-1-methylimidazole Chemical compound CN1C=CN=C1C#CC1=CC=CC=C1F GJTBRYJBWTXWBR-UHFFFAOYSA-N 0.000 claims 2
- HBRGCNVGMLCWFB-UHFFFAOYSA-N 2-[2-(4-butoxyphenyl)ethenyl]-1-methyl-4,5-di(propan-2-yl)imidazole Chemical compound C1=CC(OCCCC)=CC=C1C=CC1=NC(C(C)C)=C(C(C)C)N1C HBRGCNVGMLCWFB-UHFFFAOYSA-N 0.000 claims 2
- LCAZPXPSEZKQCH-UHFFFAOYSA-N 2-[2-(4-chloro-3-fluorophenyl)ethenyl]-1-methyl-4,5-di(propan-2-yl)imidazole Chemical compound CN1C(C(C)C)=C(C(C)C)N=C1C=CC1=CC=C(Cl)C(F)=C1 LCAZPXPSEZKQCH-UHFFFAOYSA-N 0.000 claims 2
- BWTWHMPAYLJQHG-UHFFFAOYSA-N 2-[2-(4-chlorophenyl)ethenyl]-1-methyl-4,5-di(propan-2-yl)imidazole Chemical compound CN1C(C(C)C)=C(C(C)C)N=C1C=CC1=CC=C(Cl)C=C1 BWTWHMPAYLJQHG-UHFFFAOYSA-N 0.000 claims 2
- ZPWBQDTXNYUEMH-UHFFFAOYSA-N 2-[2-(4-ethoxyphenyl)ethenyl]-1-methyl-4,5-di(propan-2-yl)imidazole Chemical compound C1=CC(OCC)=CC=C1C=CC1=NC(C(C)C)=C(C(C)C)N1C ZPWBQDTXNYUEMH-UHFFFAOYSA-N 0.000 claims 2
- ITCZVFALFXJYIH-UHFFFAOYSA-N 2-[2-(4-fluorophenyl)ethenyl]-1-methyl-4,5-di(propan-2-yl)imidazole Chemical compound CN1C(C(C)C)=C(C(C)C)N=C1C=CC1=CC=C(F)C=C1 ITCZVFALFXJYIH-UHFFFAOYSA-N 0.000 claims 2
- CLGYQXXADPCCSH-UHFFFAOYSA-N 2-[2-(4-methoxy-2,3,6-trimethylphenyl)ethenyl]-1-methyl-4,5-di(propan-2-yl)imidazole Chemical compound CC1=C(C)C(OC)=CC(C)=C1C=CC1=NC(C(C)C)=C(C(C)C)N1C CLGYQXXADPCCSH-UHFFFAOYSA-N 0.000 claims 2
- GFCRCHULVWYHMO-UHFFFAOYSA-N 2-[2-(4-methoxyphenyl)ethenyl]-1-methyl-4,5-di(propan-2-yl)imidazole Chemical compound C1=CC(OC)=CC=C1C=CC1=NC(C(C)C)=C(C(C)C)N1C GFCRCHULVWYHMO-UHFFFAOYSA-N 0.000 claims 2
- MQKZEWYLKDQMMB-UHFFFAOYSA-N 2-[5-nitro-2-(2-phenylethynyl)imidazol-1-yl]ethanol Chemical compound C1=C([N+]([O-])=O)N(CCO)C(C#CC=2C=CC=CC=2)=N1 MQKZEWYLKDQMMB-UHFFFAOYSA-N 0.000 claims 2
- GZHRZQIKHYTBFX-UHFFFAOYSA-N 3-(2-phenylethynyl)-4h-imidazo[5,1-c][1,4]benzoxazine Chemical compound C=12COC3=CC=CC=C3N2C=NC=1C#CC1=CC=CC=C1 GZHRZQIKHYTBFX-UHFFFAOYSA-N 0.000 claims 2
- DFYJLEMNROIZPQ-UHFFFAOYSA-N 3-cyclopropyl-5-[3,5-dimethyl-2-(2-phenylethynyl)imidazol-4-yl]-1,2,4-oxadiazole Chemical compound CN1C(C=2ON=C(N=2)C2CC2)=C(C)N=C1C#CC1=CC=CC=C1 DFYJLEMNROIZPQ-UHFFFAOYSA-N 0.000 claims 2
- UJFQNEJMQQJVLX-UHFFFAOYSA-N 3-methyl-5-(2-phenylethynyl)imidazole-4-carbaldehyde Chemical compound CN1C=NC(C#CC=2C=CC=CC=2)=C1C=O UJFQNEJMQQJVLX-UHFFFAOYSA-N 0.000 claims 2
- BBZBDSQJXLMIPZ-UHFFFAOYSA-N 4-bromo-1-methyl-5-(2-phenylethenyl)imidazole Chemical compound CN1C=NC(Br)=C1C=CC1=CC=CC=C1 BBZBDSQJXLMIPZ-UHFFFAOYSA-N 0.000 claims 2
- CHRJDBKXAYFWBG-UHFFFAOYSA-N 5-(2-phenylethynyl)-1h-imidazole Chemical compound N1C=NC(C#CC=2C=CC=CC=2)=C1 CHRJDBKXAYFWBG-UHFFFAOYSA-N 0.000 claims 2
- RASHNUWSNZDIKZ-UHFFFAOYSA-N 5-[3,5-dimethyl-2-(2-phenylethynyl)imidazol-4-yl]-3-methyl-1,2,4-oxadiazole Chemical compound CC1=NOC(C=2N(C(C#CC=3C=CC=CC=3)=NC=2C)C)=N1 RASHNUWSNZDIKZ-UHFFFAOYSA-N 0.000 claims 2
- TWCUIQRCNHSYET-UHFFFAOYSA-N C=12CSC3=NC=CC=C3N2C=NC=1C#CC1=CC=CC=C1 Chemical compound C=12CSC3=NC=CC=C3N2C=NC=1C#CC1=CC=CC=C1 TWCUIQRCNHSYET-UHFFFAOYSA-N 0.000 claims 2
- KUZYHKPNDNYVFS-UHFFFAOYSA-N ethyl 2-[2-(2,6-dichlorophenyl)ethynyl]-3,5-dimethylimidazole-4-carboxylate Chemical compound CN1C(C(=O)OCC)=C(C)N=C1C#CC1=C(Cl)C=CC=C1Cl KUZYHKPNDNYVFS-UHFFFAOYSA-N 0.000 claims 2
- JNKNMBHRLXZDMF-UHFFFAOYSA-N ethyl 2-[2-(2-fluorophenyl)ethynyl]-3,5-dimethylimidazole-4-carboxylate Chemical compound CN1C(C(=O)OCC)=C(C)N=C1C#CC1=CC=CC=C1F JNKNMBHRLXZDMF-UHFFFAOYSA-N 0.000 claims 2
- VPSIUCDDPIYDBZ-UHFFFAOYSA-N ethyl 2-[2-(3-acetamidophenyl)ethynyl]-3,5-dimethylimidazole-4-carboxylate Chemical compound CN1C(C(=O)OCC)=C(C)N=C1C#CC1=CC=CC(NC(C)=O)=C1 VPSIUCDDPIYDBZ-UHFFFAOYSA-N 0.000 claims 2
- FBAQJTNEFQLKDI-UHFFFAOYSA-N ethyl 2-[2-(3-methoxyphenyl)ethynyl]-3,5-dimethylimidazole-4-carboxylate Chemical compound CN1C(C(=O)OCC)=C(C)N=C1C#CC1=CC=CC(OC)=C1 FBAQJTNEFQLKDI-UHFFFAOYSA-N 0.000 claims 2
- GRYFIYRDBBGSOZ-UHFFFAOYSA-N ethyl 2-[2-(4-chlorophenyl)ethynyl]-3,5-dimethylimidazole-4-carboxylate Chemical compound CN1C(C(=O)OCC)=C(C)N=C1C#CC1=CC=C(Cl)C=C1 GRYFIYRDBBGSOZ-UHFFFAOYSA-N 0.000 claims 2
- AMMUWSFTGNPEKG-UHFFFAOYSA-N ethyl 2-[2-(4-fluorophenyl)ethynyl]-3,5-dimethylimidazole-4-carboxylate Chemical compound CN1C(C(=O)OCC)=C(C)N=C1C#CC1=CC=C(F)C=C1 AMMUWSFTGNPEKG-UHFFFAOYSA-N 0.000 claims 2
- LFEGVWDXVWTAIG-UHFFFAOYSA-N ethyl 2-[2-[3-(2,5-dimethylpyrrol-1-yl)phenyl]ethynyl]-3,5-dimethylimidazole-4-carboxylate Chemical compound CN1C(C(=O)OCC)=C(C)N=C1C#CC1=CC=CC(N2C(=CC=C2C)C)=C1 LFEGVWDXVWTAIG-UHFFFAOYSA-N 0.000 claims 2
- UDUUYNGUGLDJSB-UHFFFAOYSA-N ethyl 2-[4,5-dichloro-2-(2-phenylethynyl)imidazol-1-yl]acetate Chemical compound CCOC(=O)CN1C(Cl)=C(Cl)N=C1C#CC1=CC=CC=C1 UDUUYNGUGLDJSB-UHFFFAOYSA-N 0.000 claims 2
- QIZMLYHJXFXAKQ-UHFFFAOYSA-N ethyl 3,5-dimethyl-2-(2-phenylethynyl)imidazole-4-carboxylate Chemical compound CN1C(C(=O)OCC)=C(C)N=C1C#CC1=CC=CC=C1 QIZMLYHJXFXAKQ-UHFFFAOYSA-N 0.000 claims 2
- MWLZTAMTGJSIKB-UHFFFAOYSA-N ethyl 3,5-dimethyl-2-[2-(3-methylphenyl)ethynyl]imidazole-4-carboxylate Chemical compound CN1C(C(=O)OCC)=C(C)N=C1C#CC1=CC=CC(C)=C1 MWLZTAMTGJSIKB-UHFFFAOYSA-N 0.000 claims 2
- STSJEIMVNKMUKM-UHFFFAOYSA-N ethyl 3,5-dimethyl-2-[2-(4-phenylphenyl)ethynyl]imidazole-4-carboxylate Chemical compound CN1C(C(=O)OCC)=C(C)N=C1C#CC1=CC=C(C=2C=CC=CC=2)C=C1 STSJEIMVNKMUKM-UHFFFAOYSA-N 0.000 claims 2
- MGECHZGQZRYAMT-UHFFFAOYSA-N ethyl 5-methyl-2-(2-phenylethynyl)-1h-imidazole-4-carboxylate Chemical compound CC1=C(C(=O)OCC)NC(C#CC=2C=CC=CC=2)=N1 MGECHZGQZRYAMT-UHFFFAOYSA-N 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 2
- DKHZUGSGUBZOCZ-UHFFFAOYSA-N n-[2-[5-methoxy-1-(2-phenylethynyl)indol-3-yl]ethyl]acetamide Chemical compound C1=C(CCNC(C)=O)C2=CC(OC)=CC=C2N1C#CC1=CC=CC=C1 DKHZUGSGUBZOCZ-UHFFFAOYSA-N 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- HGTWKNHACOBSOL-UHFFFAOYSA-N 1,3-dimethyl-5-(2-phenylethynyl)pyrazole Chemical compound CN1N=C(C)C=C1C#CC1=CC=CC=C1 HGTWKNHACOBSOL-UHFFFAOYSA-N 0.000 claims 1
- QVZVVURXTJBWAR-UHFFFAOYSA-N 1-ethyl-2-(2-phenylethenyl)imidazole Chemical compound CCN1C=CN=C1C=CC1=CC=CC=C1 QVZVVURXTJBWAR-UHFFFAOYSA-N 0.000 claims 1
- OZJKSTCQXAJSFP-UHFFFAOYSA-N 1-methyl-2-(2-phenylethenyl)imidazole Chemical compound CN1C=CN=C1C=CC1=CC=CC=C1 OZJKSTCQXAJSFP-UHFFFAOYSA-N 0.000 claims 1
- RNJGZVHFDPIYPS-UHFFFAOYSA-N 1-methyl-2-[2-(4-methylphenyl)ethenyl]imidazole Chemical compound C1=CC(C)=CC=C1C=CC1=NC=CN1C RNJGZVHFDPIYPS-UHFFFAOYSA-N 0.000 claims 1
- XSSCYCWPVNKHJD-UHFFFAOYSA-N 1-methyl-5-(2-phenylethenyl)imidazole Chemical compound CN1C=NC=C1C=CC1=CC=CC=C1 XSSCYCWPVNKHJD-UHFFFAOYSA-N 0.000 claims 1
- OPHSKKPSEMOQLM-UHFFFAOYSA-N 2-(2-phenylethenyl)-1h-imidazole Chemical compound N=1C=CNC=1C=CC1=CC=CC=C1 OPHSKKPSEMOQLM-UHFFFAOYSA-N 0.000 claims 1
- HDIOEVDERVDAPO-UHFFFAOYSA-N 2-[2-(2,4-dichlorophenyl)ethenyl]-1-methylimidazole Chemical compound CN1C=CN=C1C=CC1=CC=C(Cl)C=C1Cl HDIOEVDERVDAPO-UHFFFAOYSA-N 0.000 claims 1
- FETOXIKBUBLDHT-UHFFFAOYSA-N 2-[2-(2,4-dichlorophenyl)ethenyl]-1h-imidazole Chemical compound ClC1=CC(Cl)=CC=C1C=CC1=NC=CN1 FETOXIKBUBLDHT-UHFFFAOYSA-N 0.000 claims 1
- AHFRJJJSASSBCT-UHFFFAOYSA-N 2-[2-(3-methoxyphenyl)ethenyl]-1-methyl-5-nitroimidazole Chemical compound COC1=CC=CC(C=CC=2N(C(=CN=2)[N+]([O-])=O)C)=C1 AHFRJJJSASSBCT-UHFFFAOYSA-N 0.000 claims 1
- XKFYBJSCRUSTBT-UHFFFAOYSA-N 2-[2-(4-chlorophenyl)ethenyl]-1-methylimidazole Chemical compound CN1C=CN=C1C=CC1=CC=C(Cl)C=C1 XKFYBJSCRUSTBT-UHFFFAOYSA-N 0.000 claims 1
- BSMDKDMKIOXZIM-UHFFFAOYSA-N 2-[2-(4-methoxyphenyl)ethynyl]-1-methylimidazole Chemical compound C1=CC(OC)=CC=C1C#CC1=NC=CN1C BSMDKDMKIOXZIM-UHFFFAOYSA-N 0.000 claims 1
- WBHLBULNUPMEDL-UHFFFAOYSA-N 2-[2-[2-(3-methoxyphenyl)ethenyl]-5-nitroimidazol-1-yl]ethanol Chemical compound COC1=CC=CC(C=CC=2N(C(=CN=2)[N+]([O-])=O)CCO)=C1 WBHLBULNUPMEDL-UHFFFAOYSA-N 0.000 claims 1
- PTLYSKYXEVWYRM-UHFFFAOYSA-N 4,5-dimethyl-2-(2-phenylethenyl)-1h-imidazole Chemical compound N1C(C)=C(C)N=C1C=CC1=CC=CC=C1 PTLYSKYXEVWYRM-UHFFFAOYSA-N 0.000 claims 1
- -1 4-amino-phenylethynyl Chemical group 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- AETOAKAJYVULJF-UHFFFAOYSA-N ethyl 2-[2-(4-aminophenyl)ethynyl]-3,5-dimethylimidazole-4-carboxylate Chemical compound CN1C(C(=O)OCC)=C(C)N=C1C#CC1=CC=C(N)C=C1 AETOAKAJYVULJF-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00126615 | 2000-12-04 | ||
| PCT/EP2001/013714 WO2002046166A1 (en) | 2000-12-04 | 2001-11-26 | Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007325072A Division JP2008169206A (ja) | 2000-12-04 | 2007-12-17 | グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004520292A JP2004520292A (ja) | 2004-07-08 |
| JP2004520292A5 true JP2004520292A5 (enExample) | 2005-05-26 |
| JP4077317B2 JP4077317B2 (ja) | 2008-04-16 |
Family
ID=8170567
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002547905A Expired - Fee Related JP4077317B2 (ja) | 2000-12-04 | 2001-11-26 | グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体 |
| JP2007325072A Pending JP2008169206A (ja) | 2000-12-04 | 2007-12-17 | グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007325072A Pending JP2008169206A (ja) | 2000-12-04 | 2007-12-17 | グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体 |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US6706707B2 (enExample) |
| EP (1) | EP1349839B8 (enExample) |
| JP (2) | JP4077317B2 (enExample) |
| KR (1) | KR100515549B1 (enExample) |
| CN (1) | CN1257894C (enExample) |
| AR (1) | AR035401A1 (enExample) |
| AT (1) | ATE288898T1 (enExample) |
| AU (2) | AU2002229567B2 (enExample) |
| BG (1) | BG107877A (enExample) |
| BR (1) | BR0115871A (enExample) |
| CA (1) | CA2430696C (enExample) |
| CZ (1) | CZ20031795A3 (enExample) |
| DE (1) | DE60108900T2 (enExample) |
| DK (1) | DK1349839T3 (enExample) |
| EC (1) | ECSP034640A (enExample) |
| ES (1) | ES2248410T3 (enExample) |
| HR (1) | HRP20030429A2 (enExample) |
| HU (1) | HUP0400570A3 (enExample) |
| IL (2) | IL155999A0 (enExample) |
| MA (1) | MA26971A1 (enExample) |
| MX (1) | MXPA03004862A (enExample) |
| NO (1) | NO324326B1 (enExample) |
| NZ (1) | NZ525917A (enExample) |
| PL (1) | PL366222A1 (enExample) |
| PT (1) | PT1349839E (enExample) |
| RS (1) | RS43903A (enExample) |
| RU (1) | RU2284323C9 (enExample) |
| SI (1) | SI1349839T1 (enExample) |
| SK (1) | SK8402003A3 (enExample) |
| WO (1) | WO2002046166A1 (enExample) |
| ZA (1) | ZA200303870B (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0128996D0 (en) * | 2001-12-04 | 2002-01-23 | Novartis Ag | Organic compounds |
| WO2004014902A2 (en) * | 2002-08-09 | 2004-02-19 | Astrazeneca Ab | Compounds having an activity at metabotropic glutamate receptors |
| TW200424183A (en) * | 2002-08-09 | 2004-11-16 | Nps Pharma Inc | New compounds |
| CN1894241A (zh) | 2002-08-09 | 2007-01-10 | 阿斯利康(瑞典)有限公司 | 作为代谢型谷氨酸受体－5调节剂的“1,2,4” 噁二唑 |
| ITMI20030151A1 (it) * | 2003-01-30 | 2004-07-31 | Recordati Ind Chimica E Farma Ceutica S P A | Uso di antagonisti selettivi del recettore mglu5 per il trattamento di disfunzioni neuromuscolari del tratto urinario inferiore. |
| PT1603877E (pt) | 2003-03-04 | 2009-02-11 | Addex Pharma Sa | Novos derivados de aminopiridina como antagonistas de mglur5 |
| MXPA05009290A (es) | 2003-03-07 | 2006-05-31 | Astellas Pharma Inc | Derivados heterociclicos que contienen nitrogeno que tienen estirilo 2,6-disustituido. |
| TWI292318B (en) | 2003-03-10 | 2008-01-11 | Hoffmann La Roche | Imidazol-4-yl-ethynyl-pyridine derivatives |
| JP2006521358A (ja) * | 2003-03-26 | 2006-09-21 | メルク エンド カムパニー インコーポレーテッド | 代謝調節型グルタミン酸受容体のベンズアミドモジュレータ |
| US7531529B2 (en) | 2003-06-05 | 2009-05-12 | Roche Palo Alto Llc | Imidazole derivatives |
| UA80888C2 (en) | 2003-06-05 | 2007-11-12 | Hoffmann La Roche | Imidazole derivatives as glutmate receptor antagonists |
| AU2004247368B2 (en) | 2003-06-12 | 2007-11-22 | F. Hoffmann-La Roche Ag | Heteroaryl-substituted imidazole derivatives as glutamate receptor antagonists |
| WO2005094822A1 (en) | 2004-03-22 | 2005-10-13 | Eli Lilly And Company | Pyridyl derivatives and their use as mglu5 receptor antagonists |
| US7667041B2 (en) * | 2004-05-26 | 2010-02-23 | Eisai R&D Management Co., Ltd. | Cinnamide compound |
| CA2568725C (en) * | 2004-06-01 | 2012-11-27 | F. Hoffmann-La Roche Ag | Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists |
| NZ551253A (en) | 2004-06-01 | 2010-07-30 | Hoffmann La Roche | Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as MGLU5 receptor antagonists |
| GB0413605D0 (en) * | 2004-06-17 | 2004-07-21 | Addex Pharmaceuticals Sa | Novel compounds |
| DE102004044884A1 (de) * | 2004-09-14 | 2006-05-24 | Grünenthal GmbH | Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen |
| ATE458729T1 (de) | 2004-10-26 | 2010-03-15 | Eisai R&D Man Co Ltd | Amorphe form einer zimtsäureamidverbindung |
| WO2006071730A1 (en) * | 2004-12-27 | 2006-07-06 | Astrazeneca Ab | Pyrazolone compounds as metabotropic glutamate receptor agonists for the treatment of neurological and psychiatric disorders |
| RU2401258C2 (ru) * | 2005-03-16 | 2010-10-10 | Авентис Фармасьютикалз Инк. | Дипиразолы в качестве средств для центральной нервной системы |
| EP1863818B1 (en) * | 2005-03-23 | 2010-03-10 | F.Hoffmann-La Roche Ag | Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists |
| GB0508319D0 (en) | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
| US20090270623A1 (en) * | 2005-11-18 | 2009-10-29 | Naoyuki Shimomura | Process for production of cinnamide derivative |
| US20090048448A1 (en) * | 2005-11-18 | 2009-02-19 | Ikuo Kushida | Salts of cynnamide compound or solvates thereof |
| KR20080069221A (ko) * | 2005-11-24 | 2008-07-25 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 모르폴린 타입의 신나미드 화합물 |
| TWI370130B (en) | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
| AU2006328198B2 (en) * | 2005-12-19 | 2013-07-18 | Medizinische Hochschule Hannover | Substituted phenol derivatives as analgesics |
| DE102005062985A1 (de) * | 2005-12-28 | 2007-07-05 | Grünenthal GmbH | Substituierte bis(hetero)aromatische N-Ethylpropiolamide und ihre Verwendung zur Herstellung von Arzneimitteln |
| PL1992618T3 (pl) * | 2006-03-09 | 2012-06-29 | Eisai R&D Man Co Ltd | Policykliczna pochodna cynamidowa |
| TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
| DE102006011574A1 (de) | 2006-03-10 | 2007-10-31 | Grünenthal GmbH | Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln |
| US7737141B2 (en) * | 2006-07-28 | 2010-06-15 | Eisai R&D Management Co., Ltd. | Prodrug of cinnamide compound |
| HRP20160950T1 (hr) | 2006-12-21 | 2016-10-07 | F. Hoffmann-La Roche Ag | Polimorfi antagonista mglur5 receptora |
| US20080207900A1 (en) | 2007-02-28 | 2008-08-28 | Teiji Kimura | Two cyclic oxomorphorin derivatives |
| CA2687262A1 (en) * | 2007-05-16 | 2008-11-20 | Naoyuki Shimomura | One-pot production process for cinnamide derivative |
| US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
| TW200916469A (en) * | 2007-08-31 | 2009-04-16 | Eisai R & Amp D Man Co Ltd | Multi-cyclic compounds |
| AU2009210070A1 (en) * | 2008-01-28 | 2009-08-06 | Eisai R & D Management Co., Ltd. | Crystalline cinnamide compounds or salts thereof |
| US8323805B2 (en) | 2009-06-04 | 2012-12-04 | Nitto Denko Corporation | Emissive aryl-heteroaryl acetylenes |
| US8334287B2 (en) | 2009-07-17 | 2012-12-18 | Hoffmann-La Roche Inc. | Imidazoles |
| US8642626B2 (en) | 2010-07-29 | 2014-02-04 | Taisho Pharmaceutical Co., Ltd. | Ethinyl-pyrazole derivative |
| HUE040156T2 (hu) * | 2010-11-05 | 2019-02-28 | Oat Agrio Co Ltd | Etinilfenilamidinvegyület vagy sója, eljárás azok elõállítására, és fungicid mezõgazdasági és kertészeti alkalmazásra |
| WO2012172093A1 (en) * | 2011-06-17 | 2012-12-20 | Merz Pharma Gmbh & Co. Kgaa | Dihydroindolizine derivate as metabotropic glutamate receptor modulators |
| KR101291037B1 (ko) * | 2011-10-12 | 2013-08-01 | 사회복지법인 삼성생명공익재단 | 레스베라트롤 유도체와 스티릴-오각형 방향족 화합물 및 이들의 베타-아밀로이드 플라그에 대한 결합제 및 진단영상제의 용도 |
| EP3400220B1 (en) * | 2016-01-05 | 2021-03-24 | Hua Medicine (Shanghai) Ltd. | Pyrazole derivatives |
| US10669255B2 (en) | 2016-04-06 | 2020-06-02 | Hua Medicine (Shanghai) Ltd. | Pyrrole derivatives |
| MX2019008230A (es) | 2017-01-10 | 2019-10-24 | Bayer Ag | Derivados heterociclicos como agentes de control de plagas. |
| KR20200035035A (ko) | 2017-07-31 | 2020-04-01 | 노파르티스 아게 | 코카인 사용 감소 또는 코카인 사용 재발 예방에 있어서 마보글루란트의 용도 |
| US12479816B2 (en) | 2019-02-08 | 2025-11-25 | University of Pittsburgh—of the Commonwealth System of Higher Education | 20-HETE formation inhibitors |
| EP4069685A1 (en) * | 2019-12-02 | 2022-10-12 | F. Hoffmann-La Roche AG | Alkynyl-(heteroaryl)-carboxamide hcn1 inhibitors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3303199A (en) | 1963-07-15 | 1967-02-07 | Geigy Chem Corp | Certain imidazolone derivatives and process for making same |
| US3341548A (en) | 1964-04-29 | 1967-09-12 | Hoffmann La Roche | Nitroimidazoles and their preparation |
| DE2035905A1 (de) * | 1970-07-20 | 1972-02-03 | Chemische Fabrik Stockhausen & Cie.,4150Krefeld | Imidazolverbindungen und deren Herstellungsverfahren |
| CA1174673A (en) | 1981-02-27 | 1984-09-18 | Walter Hunkeler | Imidazodiazepines |
| US4711962A (en) | 1984-10-18 | 1987-12-08 | Stauffer Chemical Company | Process for selective preparation of ratios of isomers formed on N-substitution of asymmetric imidazoles |
| HU217958B (hu) | 1989-06-30 | 2000-05-28 | E. I. Du Pont De Nemours And Co. | Helyettesített imidazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra |
| US5821937A (en) * | 1996-02-23 | 1998-10-13 | Netsuite Development, L.P. | Computer method for updating a network design |
| TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
| CA2297732C (en) * | 1997-08-14 | 2008-04-29 | F. Hoffmann-La Roche Ag | Heterocyclic vinylethers against neurological disorders |
| US6377987B1 (en) * | 1999-04-30 | 2002-04-23 | Cisco Technology, Inc. | Mechanism for determining actual physical topology of network based on gathered configuration information representing true neighboring devices |
| CA2383524C (en) * | 1999-08-31 | 2010-09-28 | Merck & Co., Inc. | Thiazolyl alkynyl compounds and methods of use thereof |
-
2001
- 2001-11-26 AT AT01990437T patent/ATE288898T1/de active
- 2001-11-26 AU AU2002229567A patent/AU2002229567B2/en not_active Ceased
- 2001-11-26 DK DK01990437T patent/DK1349839T3/da active
- 2001-11-26 IL IL15599901A patent/IL155999A0/xx unknown
- 2001-11-26 SI SI200130304T patent/SI1349839T1/xx unknown
- 2001-11-26 CN CNB018199933A patent/CN1257894C/zh not_active Expired - Fee Related
- 2001-11-26 EP EP01990437A patent/EP1349839B8/en not_active Expired - Lifetime
- 2001-11-26 NZ NZ525917A patent/NZ525917A/en unknown
- 2001-11-26 PL PL01366222A patent/PL366222A1/xx unknown
- 2001-11-26 MX MXPA03004862A patent/MXPA03004862A/es active IP Right Grant
- 2001-11-26 BR BR0115871-6A patent/BR0115871A/pt not_active Application Discontinuation
- 2001-11-26 JP JP2002547905A patent/JP4077317B2/ja not_active Expired - Fee Related
- 2001-11-26 CZ CZ20031795A patent/CZ20031795A3/cs unknown
- 2001-11-26 HU HU0400570A patent/HUP0400570A3/hu unknown
- 2001-11-26 HR HR20030429A patent/HRP20030429A2/hr not_active Application Discontinuation
- 2001-11-26 PT PT01990437T patent/PT1349839E/pt unknown
- 2001-11-26 RU RU2003119548/04A patent/RU2284323C9/ru not_active IP Right Cessation
- 2001-11-26 ES ES01990437T patent/ES2248410T3/es not_active Expired - Lifetime
- 2001-11-26 KR KR10-2003-7007421A patent/KR100515549B1/ko not_active Expired - Fee Related
- 2001-11-26 RS YU43903A patent/RS43903A/sr unknown
- 2001-11-26 AU AU2956702A patent/AU2956702A/xx active Pending
- 2001-11-26 CA CA002430696A patent/CA2430696C/en not_active Expired - Fee Related
- 2001-11-26 DE DE60108900T patent/DE60108900T2/de not_active Expired - Lifetime
- 2001-11-26 WO PCT/EP2001/013714 patent/WO2002046166A1/en not_active Ceased
- 2001-11-26 SK SK840-2003A patent/SK8402003A3/sk unknown
- 2001-11-28 US US09/996,641 patent/US6706707B2/en not_active Expired - Fee Related
- 2001-12-03 AR ARP010105602A patent/AR035401A1/es unknown
-
2003
- 2003-03-25 US US10/396,172 patent/US6972299B2/en not_active Expired - Fee Related
- 2003-04-04 US US10/407,929 patent/US6927232B2/en not_active Expired - Fee Related
- 2003-05-19 ZA ZA200303870A patent/ZA200303870B/en unknown
- 2003-05-19 IL IL155999A patent/IL155999A/en not_active IP Right Cessation
- 2003-06-03 EC EC2003004640A patent/ECSP034640A/es unknown
- 2003-06-03 NO NO20032503A patent/NO324326B1/no not_active IP Right Cessation
- 2003-06-04 MA MA27192A patent/MA26971A1/fr unknown
- 2003-06-04 BG BG107877A patent/BG107877A/bg unknown
-
2005
- 2005-01-18 US US11/037,904 patent/US20050131043A1/en not_active Abandoned
-
2007
- 2007-12-17 JP JP2007325072A patent/JP2008169206A/ja active Pending